Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Infection Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00488046
What this trial is testing

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 16
Testing effectiveness (Phase 2)Ended earlyNCT04388683
What this trial is testing

Inhaled Nitric Oxide for Preventing Progression in COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 10
Not applicableStudy completedNCT00306982
What this trial is testing

Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™

Who this might be right for
Influenza
GlaxoSmithKline 1,524
Large-scale testing (Phase 3)Study completedNCT02430259
What this trial is testing

Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention

Who this might be right for
SilicosisTuberculosis
Huashan Hospital 566
Large-scale testing (Phase 3)Study completedNCT04368559
What this trial is testing

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
CandidemiaMycosesFungal Infection+7 more
Mundipharma Research Limited 602
Post-approval studies (Phase 4)Ended earlyNCT02034279
What this trial is testing

The INFECIR-2 Albumin Prevention Study

Who this might be right for
Advanced Chronic Liver DiseaseUrinary InfectionPneumonia+2 more
EASL - CLIF Consortium 136
Early research (Phase 1)Not Yet RecruitingNCT07791186
What this trial is testing

Safety, Tolerability, and Immunogenicity of BMI2012 Against COVID-19 Variant in Healthy Adults Aged 19 and 55 Years

Who this might be right for
Prevention of COVID-19 Variant (Omicron JN.1)
BMI Korea 72
Large-scale testing (Phase 3)Looking for participantsNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02940626
What this trial is testing

Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.

Who this might be right for
Pneumonia, Ventilator-associatedPneumonia, Staphylococcal
Arsanis, Inc. 155
Large-scale testing (Phase 3)WithdrawnNCT04452643
What this trial is testing

Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel

Who this might be right for
Covid19
Inmunotek S.L.
Large-scale testing (Phase 3)Ended earlyNCT05331885
What this trial is testing

A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2

Who this might be right for
Ventilator Associated PneumoniaStaphylococcus Aureus
Aridis Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Study completedNCT04625725
What this trial is testing

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Who this might be right for
COVID-19
AstraZeneca 5,197
Large-scale testing (Phase 3)Study completedNCT05071313
What this trial is testing

An Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Who this might be right for
Influenza, Human PreventionRespiratory Syncytial Viruses Prevention
Janssen Vaccines & Prevention B.V. 777
Not applicableStudy completedNCT05130749
What this trial is testing

Infection Prevention and Control Practices Regarding COVID-19

Who this might be right for
COVID-19 Pandemic
King Saud University 198
Not applicableUnknownNCT02231047
What this trial is testing

64N Nutraceutical for the Prevention of Childhood Diarrhea and Pneumonia in Low Resource Settings

Who this might be right for
DiarrheaPneumonia
H2O Health and Agriculture LLC 50
Testing effectiveness (Phase 2)Study completedNCT04760730
What this trial is testing

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
R-Pharm 100
Testing effectiveness (Phase 2)Study completedNCT01335932
What this trial is testing

Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

Who this might be right for
Acute Lung InjuryAcute Respiratory Distress SyndromeRespiratory Failure
Fred Hutchinson Cancer Center 160
Not applicableStudy completedNCT05383417
What this trial is testing

No Post Intubation Laryngeal Symptoms

Who this might be right for
Sore-throatDysphoniaDysphagia+9 more
University of California, San Diego 100
Testing effectiveness (Phase 2)UnknownNCT04713488
What this trial is testing

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Who this might be right for
COVID-19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 110
Testing effectiveness (Phase 2)Study completedNCT05381454
What this trial is testing

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

Who this might be right for
Respiratory Viral InfectionAntiviral TreatmentCOVID-19
University of California, Los Angeles 80
Next Page